Cargando…

Super-Enhancer Associated Five-Gene Risk Score Model Predicts Overall Survival in Multiple Myeloma Patients

Multiple myeloma (MM) is a malignant plasma cell tumor with high heterogeneity, characterized by anemia, hypercalcemia, renal failure, and lytic bone lesions. Although various powerful prognostic factors and models have been exploited, the development of more accurate prognosis and treatment for MM...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qi, Tingting, Qu, Jian, Tu, Chao, Lu, Qiong, Li, Guohua, Wang, Jiaojiao, Qu, Qiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Cell and Developmental Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7744621/ https://www.ncbi.nlm.nih.gov/pubmed/33344452 http://dx.doi.org/10.3389/fcell.2020.596777

Ejemplares similares

Construction of a Five-Super-Enhancer-Associated-Genes Prognostic Model for Osteosarcoma Patients
por: Ouyang, Zhanbo, et al.
Publicado: (2020)

Corrigendum: Construction of a Five-Super-Enhancer-Associated-Genes Prognostic Model for Osteosarcoma Patients
por: Ouyang, Zhanbo, et al.
Publicado: (2021)

Functions and Clinical Significance of Super-Enhancers in Bone-Related Diseases
por: Qu, Jian, et al.
Publicado: (2020)

Prognostic Signatures of Metabolic Genes and Metabolism-Related Long Non-coding RNAs Accurately Predict Overall Survival for Osteosarcoma Patients
por: Chao-yang, Gong, et al.
Publicado: (2021)

Multi-Omics Integrative Bioinformatics Analyses Reveal Long Non-coding RNA Modulates Genomic Integrity via Competing Endogenous RNA Mechanism and Serves as Novel Biomarkers for Overall Survival in Lung Adenocarcinoma
por: Wang, Zhonglin, et al.
Publicado: (2021)

N6-Methylandenosine-Related lncRNAs Are Potential Biomarkers for Predicting the Overall Survival of Lower-Grade Glioma Patients
por: Tu, Zewei, et al.
Publicado: (2020)

A Novel Signature Constructed by RNA-Binding Protein Coding Genes to Improve Overall Survival Prediction of Glioma Patients
por: Tu, Zewei, et al.
Publicado: (2021)

Construction and Validation of a Novel Immunosignature for Overall Survival in Uveal Melanoma
por: Gu, Chufeng, et al.
Publicado: (2021)

Immunogenic Cell Death and Immunotherapy of Multiple Myeloma
por: Serrano-del Valle, Alfonso, et al.
Publicado: (2019)

Super Enhancer-Mediated Upregulation of HJURP Promotes Growth and Survival of t(4;14)-Positive Multiple Myeloma
por: Jia, Yunlu, et al.
Publicado: (2022)

CGRP Regulates the Age-Related Switch Between Osteoblast and Adipocyte Differentiation
por: Li, Hang, et al.
Publicado: (2021)

Corrigendum: CGRP Regulates the Age-Related Switch Between Osteoblast and Adipocyte Differentiation
por: Li, Hang, et al.
Publicado: (2021)

Commentary: Immunogenic Cell Death and Immunotherapy of Multiple Myeloma
por: Maes, Ken, et al.
Publicado: (2019)

Identification of the Pyroptosis-Related Gene Signature for Overall Survival Prediction in Patients With Hepatocellular Carcinoma
por: Liu, Shuang, et al.
Publicado: (2021)

Ferroptosis-Related IncRNAs Are Prognostic Biomarker of Overall Survival in Pancreatic Cancer Patients
por: Chen, Dongjie, et al.
Publicado: (2022)

Cuprotosis-related signature predicts overall survival in clear cell renal cell carcinoma
por: Zhang, Fan, et al.
Publicado: (2022)

Response: Commentary: Immunogenic Cell Death and Immunotherapy of Multiple Myeloma
por: Serrano Del Valle, Alfonso, et al.
Publicado: (2019)

A prognostic model for patients with primary extramedullary multiple myeloma
por: Zhang, Limei, et al.
Publicado: (2022)

Identification of a Five Autophagy Subtype-Related Gene Expression Pattern for Improving the Prognosis of Lung Adenocarcinoma
por: Zhang, Meng-Yu, et al.
Publicado: (2021)

A Complement-Related Gene Signature for Predicting Overall Survival and Immunotherapy Efficacy in Sarcoma Patients
por: Zhang, Lin, et al.
Publicado: (2022)

Development and Validation of a Ferroptosis-Related Gene Signature for Overall Survival Prediction in Lung Adenocarcinoma
por: Tian, Qi, et al.
Publicado: (2021)

A Novel Ferroptosis-Related Gene Signature for Overall Survival Prediction in Patients With Breast Cancer
por: Zhu, Lizhe, et al.
Publicado: (2021)

A Novel Overall Survival Prediction Signature Based on Cancer Stem Cell-Related Genes in Osteosarcoma
por: Xiao, Bo, et al.
Publicado: (2021)

A Novel Mitochondrial-Related Nuclear Gene Signature Predicts Overall Survival of Lung Adenocarcinoma Patients
por: Zhang, Xiangwei, et al.
Publicado: (2021)

Development and Validation of an IL6/JAK/STAT3-Related Gene Signature to Predict Overall Survival in Clear Cell Renal Cell Carcinoma
por: Zhan, Chuanchuan, et al.
Publicado: (2021)

Identification and validation of a novel cuproptosis-related gene signature in multiple myeloma
por: Zhang, Bingxin, et al.
Publicado: (2023)

A novel glycolysis-related gene signature for predicting the prognosis of multiple myeloma
por: Zhang, Bingxin, et al.
Publicado: (2023)

Targeting TGF-β signaling in the multiple myeloma microenvironment: Steering CARs and T cells in the right direction
por: Rana, Priyanka S., et al.
Publicado: (2022)

Positive Correlation Between LTA Expression and Overall Immune Activity Suggests an Increased Probability of Survival in Uterine Corpus Endometrial Carcinoma
por: Shi, Mingjie, et al.
Publicado: (2022)

m5C-Related lncRNAs Predict Overall Survival of Patients and Regulate the Tumor Immune Microenvironment in Lung Adenocarcinoma
por: Pan, Junfan, et al.
Publicado: (2021)

Angiogenesis-Related Gene Signature-Derived Risk Score for Glioblastoma: Prospects for Predicting Prognosis and Immune Heterogeneity in Glioblastoma
por: Wang, Gang, et al.
Publicado: (2022)

Inhibition of the Protein Arginine Methyltransferase PRMT5 in High-Risk Multiple Myeloma as a Novel Treatment Approach
por: Vlummens, Philip, et al.
Publicado: (2022)

An N6-Methyladenosine-Related Gene Set Variation Score as a Prognostic Tool for Lung Adenocarcinoma
por: Zhang, Huijuan, et al.
Publicado: (2021)

S100 Calcium Binding Protein Family Members Associate With Poor Patient Outcome and Response to Proteasome Inhibition in Multiple Myeloma
por: Liu, Minxia, et al.
Publicado: (2021)

Targeting RFWD2 as an Effective Strategy to Inhibit Cellular Proliferation and Overcome Drug Resistance to Proteasome Inhibitor in Multiple Myeloma
por: Guo, Mengjie, et al.
Publicado: (2021)

Small Interfering RNA for Gliomas Treatment: Overcoming Hurdles in Delivery
por: Teng, Xin-Qi, et al.
Publicado: (2022)

Super-Resolution Imaging of Plasma Membrane Proteins with Click Chemistry
por: Mateos-Gil, Pablo, et al.
Publicado: (2016)

Super-Enhancers and CTCF in Early Embryonic Cell Fate Decisions
por: Agrawal, Puja, et al.
Publicado: (2021)

Single-Cell Transcriptomes Combining with Consecutive Genomics Reveal Clonal Evolution and Gene Regulatory Networks in Relapsed and Refractory Multiple Myeloma
por: Xu, Jiadai, et al.
Publicado: (2022)

Super-Resolution Imaging Approaches for Quantifying F-Actin in Immune Cells
por: Garlick, Evelyn, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8chd5u5hmtpa16jam6o33g51bu